Literature DB >> 8186133

Global overview of Lamisil.

A Y Finlay1.   

Abstract

Terbinafine (Lamisil) is a new antifungal drug which is now available in many countries worldwide. This review seeks to summarize why terbinafine is of interest and how well it reaches its target sites--the stratum corneum and nail plate. The diseases in which it is potentially effective are described and evidence that terbinafine is of value in these diseases is cited. There are very few effective drugs which do not have some potential for producing side-effects and these are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8186133     DOI: 10.1111/j.1365-2133.1994.tb06082.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

2.  Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.

Authors:  Emilia Ghelardi; Francesco Celandroni; Sokhna Aissatou Gueye; Sara Salvetti; Sonia Senesi; Anna Bulgheroni; Federico Mailland
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

3.  Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.

Authors:  Hiroyasu Koga; Yasuko Nanjoh; Hideo Kaneda; Hideyo Yamaguchi; Ryoji Tsuboi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

4.  Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.

Authors:  A Mallat; E S Zafrani; J M Metreau; D Dhumeaux
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

5.  Intermittent pulse-dosed terbinafine in the treatment of tinea corporis and/or tinea cruris.

Authors:  V Shivakumar; Rajendra Okade; V Rajkumar; K Sajitha; S R Prasad
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

6.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

7.  Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans.

Authors:  Joanne M Kingsbury; Joseph Heitman; Sheldon R Pinnell
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

8.  Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study.

Authors:  Imran Majid; Gousia Sheikh; Farhath Kanth; Rubeena Hakak
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.